ClinicalTrialsFinder

mCRPC (Metastatic Castration-resistant Prostate Cancer) Clinical Trials in Dallas, Texas

1 recruitingDallas, Texas

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617

Prostate CancerNeoplasmsNeoplasms by Site+7 more
Pathos AI, Inc.252 enrolled18 locationsNCT06785636